Tranilast reduces mesenteric vascular collagen deposition and chymase-positive mast cells in experimental diabetes

Journal of Diabetes and its Complications

Volumn 18, Issue 5, 2004, Pages 309-315

  Jones, S E ^a   Gilbert, R E ^b   Kelly, D J ^b  

^a University Hospital of Hartlepool   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

ACE; angiotensin converting enzyme; Chymase; Cont; control rat; D+T; Diab; Diabetes; diabetic rat; diabetic rat plus tranilast; mast cell containing tryptase; Mast cells; MCT; MCTC; Mesentery; Tranilast

Indexed keywords

ANGIOTENSIN; CHYMASE; COLLAGEN; TOLONIUM CHLORIDE; TRANILAST; TRANSFORMING GROWTH FACTOR BETA; TRYPTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL INFILTRATION; CONTROLLED STUDY; DIABETIC ANGIOPATHY; IMMUNOHISTOCHEMISTRY; MALE; MAST CELL; MESENTERY; MESENTERY BLOOD VESSEL; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; VASCULAR FIBROSIS;

ANIMALS; ANTHRANILIC ACIDS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL COUNT; CHYMASES; COLLAGEN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; FIBROSIS; IMMUNOHISTOCHEMISTRY; MALE; MAST CELLS; MESENTERIC ARTERIES; RATS; RATS, SPRAGUE-DAWLEY; SERINE ENDOPEPTIDASES;

EID: 4444324067     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2004.02.002     Document Type: Article

References (44)

1. Arshi K., Bendayan M., Ghitescu L. Alterations in rat mesentery vasculature in experimental diabetes. Laboratory Investigation. 80:2000;1171-1184
2. Azuma H., Banno K., Yoshimura T. Pharmacological properties of N-(3′,4′-dimethoxycinnamoyl) anthranilic acid (N-5′), a new anti-atopic agent. British Journal of Pharmacology. 58:1976;483-488
3. Border W., Noble N. Transforming growth factor β in tissue fibrosis. New England Journal of Medicine. 331:1994;1286-1292
4. Bradding P., Okayama Y., Howarth P., Church M., Holgate S. Heterogeneity of human mast cells based on cytokine content. Journal of Immunology. 155:1995;297-307
5. Bradding P., Walls A., Church M. Mast cells and basophils: Their role in initiating and maintaining inflammatory responses. Holgate S. Immunology of the respiratory system. Vol. 53-84:1995;Academic Press, London
6. Bunag R. Validation in awake rats of a tail-cuff method for measuring systolic pressure. Journal of Applied Physiology. 34:1973;279-283
7. Caughey G. Mast cell chymases and tryptases: Phylogeny, family relationships and biogenesis. Caughey G. Mast cell proteases in immunology and biology. 1995;305-329 Marcel Dekker, New York
8. Chandrasekharan U., Sanker S., Glynias M., Karnik S., Husain A. Angiotensin II-forming activity in a reconstructed ancestral chymase. Science. 271:1996;502-505
9. Chaturvedi N., Sjolie A., Stephenson J., Abrahamian H., Keipes M., Castellarin A., Rogulja-Pepeonik Z., Fuller J.H. EUCLID Study Group Effect of lisinopril on progression of retinopathy in normotensive people with Type 1 diabetes. The EUCLID Study Group EURODIAB controlled trial of lisinopril in insulin dependent diabetes mellitus. Lancet. 351:1998;28-31
10. Claman H. On scleroderma: Mast cells, endothelial cells and fibroblasts. JAMA, Journal of the American Medical Association. 262:1989;1206-1209
11. Gilbert R., Rumble J., Cao Z., Cox A.J., van Eeden P., Allen T.J., Kelly D.J., Cooper M.E. Endothelin receptor antagonism ameliorates mast cell infiltration, vascular hypertrophy, and epidermal growth factor expression in experimental diabetes. Circulation Research. 86:2000;158-165
12. Gruber B., Marchese M., Suzuki K., Schwartz L.B., Okada Y., Nagase H., Ramamurthy N.S. Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. Journal of Clinical Investigation. 84:1989;1657-1662
13. Kawanami O., Ferrans V., Fulmer J., Crystal R. Ultra-structure of pulmonary mast cells in patients with fibrotic lung disease. Laboratory Investigation. 40:1979;717-734
14. Kelly D.J., Wilkinson-Berka J.L., Allen T.J., Cooper M.E., Skinner S.L. A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2) 27 rat (TGR). Kidney International. 54:1998;343-352
15. Langunoff D. Contribution of electron microscopy to the study of mast cells. Journal of Investigative Dermatology. 58:1972;296-311
16. Lehr H., Mankoff D., Corwin D., Santeusanio G., Gown A. Application of Photoshop-based image analysis to quantification of hormone receptor expression in breast cancer. Journal of Histochemistry and Cytochemistry. 45:1997;1559-1565
17. Lewis E., Hunsicker L., Bain R., Rohde R. The effect of angiotensin converting enzyme inhibition on diabetic nephropathy. New Engl J Med. 329:1993;1456-1462
18. Lindstedt K., Wang Y., Shiota N., Saarinin J., Hyytiainen M., Kokkonen O., Keski-Oja J., Kovanen P.I. Activation of paracrine TGF-β1 signaling upon stimulation and degranulation of rat serosal mast cells: A novel function of chymase. FASEB Journal. 15:2001;1377-1388
19. Miyazawa K., Fukuyama J., Misawa K., Hamano S., Ujiie A. Tranilast antagonizes angiotensin II and inhibits its biological effects in vascular smooth muscle cells. Atherosclerosis. 121:1996;167-173
20. Miyazawa K., Kikuchi S., Fukuyama J., Hamano S., Ujiie A. Inhibition of PDGF-, TGF-β1-induced collagen synthesis, migration and proliferation in vascular smooth muscle cells from spontaneously hypertensive rats. Atherosclerosis. 118:1995;213-221
21. Nishigaki T., Momose Y., Nayata T. Electron microscopic radiographic study of the localisation of an anti-allergic agent tranilast in rat mast cells. Cellular and Molecular Biology. 36:1990;65-71
22. Norrby K., Arnqvist H. Acute hyperglycaemia and mast-cell dependent mitogenesis. Hormone and Metabolic Research. 17:1985;626-629
23. Norrby K., Bergstrom S., Druvesfors P. Hyperplasia and growth of the true mesentery in the diabetic rat. Acta Pathologica, Microbiologica, et Immunologica Scandinavica. 91:1983;195-202
24. O'Brien E., Bennett K., Garvin M., Zderic T.W., Hinohara T., Simpson J.B., Kimura T., Nobuyoshi M., Mizgala H., Purchio A., Schwartz S.N. Big-h3, transforming growth factor-beta inducible gene, is overexpressed in atherosclerosis and restenotic human vascular lesions. Arteriosclerosis, Thrombosis, and Vascular Biology. 16:1996;576-584
25. Osman I., Garrett J., Smith R. Enzyme histochemical discrimination between tryptase and chymase in mast cells of human gut. Journal of Histochemistry and Cytochemistry. 37:1982;415-421
26. Owen C., Campbell E. Angiotensin II generation at the cell surface of activated neutrophils: Novel cathepsin-G mediated catalytic activity that is resistant to inhibition. Journal of Immunology. 160:1998;1436-1443
27. Patrick M., Dunn I., Buret A., Miller H.R.P., Huntley J.F., Gibson S., Gail D.G. Mast cell protease release and mucosal ultrastructure during intestinal anaphylaxis in the rat. Gastroenterology. 94:1988;1-9
28. Reilly C., Schechter N., Travis J. Inactivation of bradykinin and kallidin by cathepsin G and mast cell chymase. Biochemical and Biophysical Research Communications. 127:1985;443-449
29. Reilly C., Tewksbury D., Schechter N., Travis J. Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases. Journal of Biological Chemistry. 257:1982;8619-8622
30. Ruger B., Hasan Q., Greenhill N., Savis P.F., Dunbar P.R., Neale T.J. Mast cells and type VIII collagen in human diabetic nephropathy. Diabetologia. 39:1996;1215-1222
31. Rumble J., Cooper M., Soulis T., Cox A.J., Wu L.L., Youssef S., Jasik M., Jerums G., Gilbert R.E. Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products. Journal of Clinical Investigation. 99:1997;1016-1027
32. Schecter N., Fraki J., Geesin J., Lazarus G. Human skin chymotryptic proteinase. Isolation and relation to cathepsin G and rat mast cell proteinase I. Journal of Biological Chemistry. 258:1983;2973-2978
33. Soma J., Sugawara T., Huang Y.D., Nakajima J., Kawamura M. Tranilast slows the progression of advanced diabetic nephropathy. Nephron. 92:2002;693-698
34. Tamai H., Katoh K., Yamaguchi T., Hayakawa H., Kanmatsuse K., Haze K., Aizawa T., Nakanishi S., Suzuki S., Suzuki T., Takase S., Nishikawa H., Katoh O. The impact of tranilast on restenosis after coronary angioplasty: The Second Tranilast Restenosis Following Angioplasty Trial (TREAT-2). American Heart Journal. 143:2002;506-513
35. Tamai H., Katoh O., Suzuki S., Fujii K., Aizawa T., Takase S., Kurogane H., Nishikawa H., Sone T., Sakai K., Suzuki T. Impact of tranilast on restenosis after coronary angioplasty: Tranilast restenosis following angioplasty trial (TREAT). American Heart Journal. 138:1999;968-975
36. The Diabetes Control and Complications Trial (DCCT) Research Group. (1993). The effect of intensive treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus. 329, 977-986.
37. Toth T., Toth-Jakatics R., Jimi S., Ihara M., Urata M., Takebayashi S. Mast cells in rapidly progressive glomerulonephritis. Journal of the American Society of Nephrology. 10:1999;1498-1505
38. United Kingdom Prospective Diabetes Study (UKPDS) Group Effect of intensive blood glucose control with metformin on complications in overweight patients with Type 2 diabetes (UKPDS 34). Lancet. 352:1998;854-865
39. United Kingdom Prospective Diabetes Study (UKPDS) Group Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and the risk of complications in patients with Type 2 diabetes (UKPDS 33). Lancet. 352:1998;837-853
40. Wahl S., Hunt D., Wakefield L., McCartney-Francis N., Wahl L.M., Roberts A.B., Sporn M.B. Transforming growth factor-β (TGF-β) induces monocyte chemotaxis and growth factor production. Proceedings of the National Academy of Sciences USA. 84:1988;5788-5792
41. Wintroub B., Schechter J., Lazarus G., Kaempfer C., Schwartz L. Angiotensin I conversion by human and rat chymotryptic proteinases. Journal of Investigative Dermatology. 83:1984;336-339
42. Wiseman D., Polverini P., Kamp D., Leibovich S. Transforming growth factor-β (TGF-β) is chemotactic for monocytes and induces their expression of angiogenic activity. Biochemical and Biophysical Research Communications. 157:1988;793-800
43. Zampini P., Riviera A., Tridente G. In vitro inhibition of histamine release from mouse mast cells and human basophils by an anthranilic acid derivative. International Journal of Immunopharmacology. 5:1983;431-435
44. Ziyadeh F. Role of transforming growth factor beta in diabetic nephropathy. Exp Nephrology. 2:1994;137